Related Experiment Videos
Pathogenesis of heart failure. Changing conceptual paradigms
G W De Keulenaer1, D L Brutsaert
1Department of Physiology and Medicine, University of Antwerp, Belgium. gillesdk@ruca.ua.ac.be
Acta Cardiologica
|October 30, 1998
Summary
Heart failure is now understood as a complex condition driven by neurohumoral imbalances and paracrine processes, not just hemodynamics. Targeting these factors, including cytokines and endothelial dysfunction, offers new therapeutic avenues for heart failure treatment.
Area of Science:
- Cardiology
- Molecular Medicine
- Pathophysiology
Background:
- Heart failure understanding has evolved beyond hemodynamic disturbances.
- Recent research highlights the role of neurohumoral and intracardiac paracrine signaling.
Purpose of the Study:
- To re-evaluate the pathophysiology of heart failure.
- To explore the impact of neurohumoral and paracrine processes on disease progression.
- To explain the mechanisms behind therapeutic interventions in heart failure.
Main Methods:
- Review of experimental observations over the past two decades.
- Analysis of the role of activated cardiac endothelial cells and cytokines.
- Correlation of clinical benefits with molecular and cellular changes.
Main Results:
- Heart failure is a complex syndrome influenced by neurohumoral imbalances.
- Intracardiac paracrine processes mediated by cytokines and endothelial cells contribute to cardiac maladaptation.
- Clinical benefits of therapies may stem from effects on cytokines and endothelial dysfunction.
Conclusions:
- Heart failure pathophysiology involves complex molecular and cellular signaling pathways.
- Cytokines and endothelial dysfunction are key players in heart failure progression.
- Future heart failure treatments will likely target these paracrine and neurohumoral mechanisms.